The German Arzneimittelpreisverordnung – AMPreisV determins prices and price .. Legal basis are FMD /62/EU (Falsified Medicines Directive) and the. Arzneimittelpreisverordnung Mortality and health indicators, – ( selected years). 10 Health care workforce per population, – Umsatzentwicklung des Apothekenmarktes seit Mittel (hier: H.v. pharmazeutischen Erzeugnissen) , , , Arzneimittelpreisverordnung).

Author: Mezikazahn Dotaur
Country: Costa Rica
Language: English (Spanish)
Genre: Spiritual
Published (Last): 10 December 2014
Pages: 364
PDF File Size: 17.32 Mb
ePub File Size: 14.59 Mb
ISBN: 810-5-52148-611-5
Downloads: 93721
Price: Free* [*Free Regsitration Required]
Uploader: Kagagul

They will apply three and five years respectively after entry into force.

German Federal Patent Court W www. Which medicinal products can benefit from the abridged procedure for marketing authorisation and what conditions and procedure apply?

Are foreign marketing authorisations recognised in your jurisdiction? Manufacturers must provide evidence of added benefit to patients for medicinal products with new active substances immediately on launch early benefit assessment.

PSURs include the results of studies carried out with the medicinal product, both on its authorised and unauthorised uses. For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in Germany: Also Found In Patents Product liability and safety.

Official website containing relevant German legislation. Authorisation conditions The competent authority examines the efficacy, safety and adequate pharmaceutical quality of the medicinal product. For the national procedure, the applicant has the right to be granted an authorisation if the legal requirements are met, within seven months of the application section 27, Medicinal Products Act. Chapters 10 and 11 of the Medicinal Products Act contain essential provisions on pharmacovigilance.

Restrictions on dealings with healthcare professionals Intangible benefits can be obtaining an award, promoting career advancement or awarding honorary offices. The Federal Institute for Drugs and Medical Devices is normally not involved in the placing on the market of medical devices. Class actions For centuries, class actions have not been permitted in Germany.


Medicinal product regulation and product liability in Germany: overview

Ordering medicinal products from foreign mail order pharmacies is only permitted from a few countries. In general, medicinal products must be made available to patients through pharmacies, including arzneimitteloreisverordnung pharmacies. Any such liability requires a breach of a duty of care Verkehrspflicht.

Are there specific regulations for the sale of medicinal products on the internet, by e-mail and by mail order?

Change of ownership applications where, for commercial reasons, a company wishes to make a duplicate of a marketing authorisation.

Under the Medicinal Products Act, the pharmaceutical entrepreneur is liable. The assessment reports from the member state that issued the first marketing authorisation for a particular product reference member state are made available to every other member state in which authorisation is sought concerned member state. A biosimilar is similar to another biological medicinal product already approved in the EU for which marketing exclusivity rights have expired.

What remedies are available to the claimant? Most private health insurance agreements include the company’s general insurance terms and tariffs for the specific costs and other items to be reimbursed. Although it entered into force on 16 Juneits application depends on setting up a fully functional EU clinical trials portal and database, to be confirmed by an independent audit. Further grounds for product liability can apply, especially under the law of tort Deliktsrecht.

In Germany, health insurance is compulsory for the whole population.

2101 of examinations on pharmaceutical quality, therapeutic efficacy and safety, and appropriate expert opinions. In general, prescription medicinal products can only be sold to patients through pharmacies, including online pharmacies. Authorisations A clinical arzneimitteopreisverordnung in Germany can only be commenced if the competent authority approves the trial.

Insurers can and often do charge extra fees, which are currently paid as of July by the insured employee. Reforms include new regulations on medical devices and health IT see Question 3 and on clinical trials see Question 7.


ABDATA, Pharma-Daten-Service [WorldCat Identities]

This concept applies primarily to xrzneimittelpreisverordnung in areas of high medical need, where it is difficult to collect data through traditional routes and large clinical trials would unnecessarily expose patients who are unlikely to benefit from the medicinal products. Recently, the Federal Ministry of Health announced that it aims to draft a second e-Health law in the current legislative period starting Outline the regulation of clinical trials.

This happens when a pharmaceutical company does not use the authorisation for a period of three years, that is, does not place the medicinal product on the market. The same applies to enterprises and facilities that develop medicinal products, subject arzneimitgelpreisverordnung to clinical trials, residual tests or acquire or administer medicinal products. The frequency, intensity, nature and duration of the corresponding measures depend on the circumstances of each case. In case of a breach of the regulations, the regulatory authorities can withdraw, revoke and suspend a marketing authorisation.

Arzneimittel-Festbeträge – GKV-Spitzenverband

Self-employed and people with a higher income can choose private insurance instead. In the case of a generic, reference can be made to the expert report for the previous applicant’s medicinal product reference medicinal productprovided that the reference medicinal product has been authorised for at least eight years or was arzneimittelpreisverodrnung at least eight years previously.

Manufacturing authorisation is also required to manufacture medicinal products that are not authorised, for example medicinal products used arzneimittelpteisverordnung a clinical trial investigational medicinal products or not subject to authorisation.

This applies to any company involved in manufacturing medicinal products, irrespective of whether it also holds the marketing authorisation or markets the medicinal product under its name.

Author: admin